Sepsis, a major complication following trauma, burns and/or surgery, is the leading cause of death in the intensive care unit nationwide. Balanced endothelial cell activation and subsequent immune cell recruitment are essential elements of a successful host response during infection/sepsis. By contrast, sustained endothelial cell activation and excessive immune cell influx are detrimental. Our long-term objective is to develop new therapeutic approaches to normalize endothelial cell responses during infection/sepsis. The objective of this application is to determine the effects of cholinergic activation via nicotinic acetylcholine receptor (nAChR) agonists and vagus nerve stimulation on endothelial activation and leukocyte trafficking during sepsis. Our central hypothesis is that activation of nAChRs 'blunts'endothelial cell inflammatory responses and inhibits endothelial:leukocyte interactions during sepsis to improve host outcome. This hypothesis is based on our preliminary results revealing that (a) endothelial cells express alpha7-nAChRs;(b) nAChR agonists reduce endothelial cell activation and NFkappaB nuclear translocation in vitro, (c) cholinergic stimulation inhibits endothelial cell activation and leukocyte recruitment in vivo;and (d) cholinergic agonists improve survival during experimental sepsis.
In Aim 1 we will identify the cell-associated and molecular mechanisms by which cholinergic stimulation blocks endothelial cell activation by answering these questions: Does cholinergic stimulation directly (in the absence of macrophages) inhibit endothelial cell responses and leukocyte recruitment - via alpha7-nAChRs? Does the NFkappaB pathway (or other anti-inflammatory pathways) mediate the effects of cholinergic agonists on endothelial cells? In Aim 2 we will determine the effects of cholinergic stimulation (using agonists and vagus nerve stimulation) on endothelial cell activation and leukocyte influx (within several organs) during sepsis in mice. Further studies will investigate alternative mechanisms for improved survival during sepsis following cholinergic stimulation. These proposed studies are innovative because they are the first to investigate the effects of cholinergic stimulation on endothelial cell activation and leukocyte recruitment during sepsis. Relevance to Public Health: Sepsis (or the body's inflammatory response to severe infection) is the #1 cause of death in the intensive care unit in the US, costing $16B per year. Many studies show the role of endothelial cells (cells that line all blood vessels in the body) in controlling the body's responses during sepsis/infection. Our studies show that endothelial cells express a protein (alpha7R) capable of turning 'OFF'dangerous/deadly inflammatory responses. We propose to investigate how excessive endothelial cell responses can be controlled through the alpha7R to improve survival during infection/sepsis. These studies are expected to lead to a treatment for sepsis in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM070727-05
Application #
7808744
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Somers, Scott D
Project Start
2006-05-01
Project End
2012-04-30
Budget Start
2010-05-01
Budget End
2012-04-30
Support Year
5
Fiscal Year
2010
Total Cost
$244,264
Indirect Cost
Name
Feinstein Institute for Medical Research
Department
Type
DUNS #
110565913
City
Manhasset
State
NY
Country
United States
Zip Code
11030
Chatterjee, Prodyot K; Yeboah, Michael M; Dowling, Oonagh et al. (2012) Nicotinic acetylcholine receptor agonists attenuate septic acute kidney injury in mice by suppressing inflammation and proteasome activity. PLoS One 7:e35361
Al-Abed, Yousef; Metz, Christine N; Cheng, Kai Fan et al. (2011) Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity. Proc Natl Acad Sci U S A 108:8224-7
Huston, Jared M; Rosas-Ballina, Mauricio; Xue, Xiangying et al. (2009) Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J Immunol 183:552-9
Chatterjee, Prodyot K; Al-Abed, Yousef; Sherry, Barbara et al. (2009) Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation. Am J Physiol Cell Physiol 297:C1294-306
Reichert, Virginia; Xue, Xiangying; Bartscherer, Diane et al. (2009) A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease. Chest 136:212-9
Yeboah, Michael M; Xue, Xiangying; Javdan, Mohammad et al. (2008) Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury. Am J Physiol Renal Physiol 295:F654-61
Yeboah, M M; Xue, X; Duan, B et al. (2008) Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int 74:62-9